相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。In vitro and in vivo study of a nanoliposomal cisplatin as a radiosensitizer
Xiaomeng Zhang et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2011)
LONG-TERM FAILURE PATTERNS AND SURVIVAL IN A RANDOMIZED DOSE-ESCALATION TRIAL FOR PROSTATE CANCER. WHO DIES OF DISEASE?
Deborah A. Kuban et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?
Margot Zoeller
NATURE REVIEWS CANCER (2011)
Stable alterations of CD44 isoform expression in prostate cancer cells decrease invasion and growth and alter ligand binding and chemosensitivity
Kui Yang et al.
BMC CANCER (2010)
Normal and malignant epithelial cells with stem-like properties have an extended G2 cell cycle phase that is associated with apoptotic resistance
Lisa J. Harper et al.
BMC CANCER (2010)
Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression
J. Hao et al.
BRITISH JOURNAL OF CANCER (2010)
CD44 Expression Predicts Local Recurrence after Radiotherapy in Larynx Cancer
Monique C. de Jong et al.
CLINICAL CANCER RESEARCH (2010)
CD147/EMMPRIN and CD44 are Potential Therapeutic Targets for Metastatic Prostate Cancer
J. L. Hao et al.
CURRENT CANCER DRUG TARGETS (2010)
IMPACT OF GENOMIC METHYLATION ON RADIATION SENSITIVITY OF COLORECTAL CARCINOMA
Barbara Hofstetter et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Prognostic value of pretreatment CD44 mRNA in peripheral blood of patients with locally advanced head and neck cancer
Jen-Tsun Lin et al.
ORAL ONCOLOGY (2010)
Use of γH2AX and Other Biomarkers of Double-Strand Breaks During Radiotherapy
Ali Sak et al.
SEMINARS IN RADIATION ONCOLOGY (2010)
Survival and self-renewing capacity of breast cancer initiating cells during fractionated radiation treatment
Chann Lagadec et al.
BREAST CANCER RESEARCH (2010)
Coexpression of invasive markers (uPA, CD44) and multiple drug-resistance proteins (MDR1, MRP2) is correlated with epithelial ovarian cancer progression
H. Chen et al.
BRITISH JOURNAL OF CANCER (2009)
Association of reactive oxygen species levels and radioresistance in cancer stem cells
Maximilian Diehn et al.
NATURE (2009)
Tumour-initiating cells: challenges and opportunities for anticancer drug discovery
Bin-Bing S. Zhou et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Moderate Dose Escalation in Three-Dimensional Conformal Localized Prostate Cancer Radiotherapy Single-institutional Experience in 398 Patients Comparing 66Gy versus 70Gy versus 74Gy
Gregor Goldner et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2009)
CD44+CD24- prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis
E. M. Hurt et al.
BRITISH JOURNAL OF CANCER (2008)
Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells
Lilly Y. W. Bourguignon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Nutlin-3 radiosensitizes hypoxic prostate cancer cells independent of p53
Stephane Supiot et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Involvement of CD44, a molecule with a thousand faces, in cancer dissemination
David Naor et al.
SEMINARS IN CANCER BIOLOGY (2008)
What dose of external-beam radiation is high enough for prostate cancer?
Thomas N. Eade et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
WNT/β-catenin mediates radiation resistance of mouse mammary progenitor cells
Wendy A. Woodward et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The response of CD24-/low/CD44+ breast cancer-initiating cells to radiation
Tiffany M. Phillips et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao et al.
NATURE (2006)
Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells
L Patrawala et al.
ONCOGENE (2006)
Prostate cancer invasion is influenced more by expression of a CD44 isoform including variant 9 than by Muc18
AL Omara-Opyene et al.
LABORATORY INVESTIGATION (2004)
CD44: From adhesion molecules to signalling regulators
H Ponta et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
分享论文
